drugset / Trial / NCT05651789

Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding

NCT05651789

RandomizedParallel-groupOpen-labelPrevention

Summary

This randomized controlled trial was conducted to evaluate the efficacy and safety of carvedilol versus propranolol, combined with routine endoscopic treatment, in the secondary prophylaxis of variceal bleeding in patients with cirrhosis.

Timeline

Start
2023-01
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 12.5 mg
Comparator Propranolol Small molecule 160 mg